| General Director of the Gustave Roussy, Paris, France Fomer Head, Multidisciplinary Oncology & Innovative Therapies Department, Nord Hospital, Marseille Fomer Head, Marseille Centre for Early Trials in Oncology Professor of Medicine, the Paris Saclay University, France General Director of the Gustave Roussy, Paris and a Professor specialising in thoracic oncology at the Paris Saclay University. He has been head of the Multidisciplinary Oncology and Innovative Therapies Department of the Nord Hospital in Marseille (Marseille Public Hospitals) and the Marseille Centre for Early Trials in Oncology (CLIP2) which were established by him. Professor Barlesi was also a co-founder of the Marseille Immunopôle French Immunology network, which aims to coordinate immunological expertise in the Aix-Marseille metropolitan area. In this context, he has organised PIONeeR (Investment in the future RHU 2017), the major international Hospital-University research project whose objective is to improve understanding of resistance to immunotherapy – anti-PD1(L1) – in lung cancer and help to prevent and overcome it. He was also vice-chair of the PACA (Provence, Alps and Côte d’Azur) Region Cancer Research Directorate. Professor Barlesi is the author and co-author of some 400 articles in international journals and specialist publications. In 2018, the European Society of Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) awarded him the prestigious Heine H. Hansen prize. He appears in the 2024 world list of most influential researchers (Highly cited researchers, Web of Science Group). |